These studies have identified a novel mechanism by which MD2 plays a pathogenic role in NAFLD through TBK1‐AMPK/SREBP1 and lipid metabolism pathway (working model shown in the graphical abstract). The gene discussed is PRKAA1; the disease is metabolic dysfunction-associated steatotic liver disease.